A detailed history of Paradigm Capital Management Inc transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Paradigm Capital Management Inc holds 4,664,100 shares of MDXG stock, worth $43 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares
4,664,100
Previous 4,167,200 11.92%
Holding current value
$43 Million
Previous $28.9 Million 4.55%
% of portfolio
1.25%
Previous 1.33%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.65 - $7.76 $2.81 Million - $3.86 Million
496,900 Added 11.92%
4,664,100 $27.6 Million
Q2 2024

Aug 14, 2024

BUY
$6.16 - $8.08 $1.59 Million - $2.09 Million
258,700 Added 6.62%
4,167,200 $28.9 Million
Q1 2024

May 15, 2024

BUY
$7.61 - $8.63 $3.64 Million - $4.13 Million
478,100 Added 13.94%
3,908,500 $30.1 Million
Q4 2023

Feb 13, 2024

SELL
$5.7 - $9.14 $285,000 - $457,000
-50,000 Reduced 1.44%
3,430,400 $30.1 Million
Q2 2023

Aug 14, 2023

BUY
$3.14 - $6.61 $94,193 - $198,286
29,998 Added 0.87%
3,480,400 $23 Million
Q1 2023

May 12, 2023

BUY
$2.97 - $4.81 $4.77 Million - $7.72 Million
1,605,102 Added 86.98%
3,450,402 $11.8 Million
Q4 2022

Feb 03, 2023

BUY
$2.63 - $3.45 $1.86 Million - $2.44 Million
708,000 Added 62.25%
1,845,300 $5.13 Million
Q3 2022

Oct 26, 2022

BUY
$2.71 - $4.22 $2.97 Million - $4.62 Million
1,094,300 Added 2544.88%
1,137,300 $3.26 Million
Q2 2022

Aug 02, 2022

BUY
$3.17 - $5.0 $136,310 - $215,000
43,000 New
43,000 $149,000
Q1 2018

Apr 09, 2018

SELL
$6.69 - $17.96 $2.8 Million - $7.53 Million
-419,100 Closed
0 $0
Q4 2017

Feb 07, 2018

BUY
$10.87 - $13.9 $108,699 - $139,000
10,000 Added 2.44%
419,100 $5.29 Million
Q3 2017

Nov 06, 2017

BUY
$11.86 - $17.34 $355,800 - $520,200
30,000 Added 7.91%
409,100 $4.86 Million
Q2 2017

Aug 10, 2017

BUY
N/A
379,100
379,100 $5.68 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.05B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Paradigm Capital Management Inc Portfolio

Follow Paradigm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.